Advancing effective antibody-based therapeutics discovery assays

Originally Aired November 18th, 2021

Already registered?

Click Here

Antibody-based therapeutics hold great promise in treatment and prevention of multiple diseases such as cancer and infectious diseases. Effective assays for functional characterization of antibody-based therapeutics are critical due to the time- and resource- consuming process of antibody-based therapeutics discovery. There have been recent advances in assay systems in the functional characterization of antibody-based therapeutics.

Join us for this webinar with Robert Carnahan (Vanderbilt University) to discuss a cell-based platform for rapid antiviral therapeutic antibody discovery and characterization, Lauriane Cabon (Roche, Switzerland) to discuss 3D culture platforms for predicting toxicity of cancer antibody-based therapeutics, and Kyoji Tsuchikama (UTHealth) to discuss the use of live cell assays to interrogate the use of proper antibody-drug conjugate (ADC) linkers to successfully implement ADC-based chemotherapy.

Registration

Sign Up:

(*) denotes required form field(s)

WorkCast's registration process uses cookies, by submitting this registration form you agree to our cookie policy.

Register  

Presenters:

Presenter
Robert Carnahan
Associate Professor of Pediatrics and Radiology & Radiological Sciences;
Associate Director, Vanderbilt Vaccine Center;
Vanderbilt University Medical Center
View Biography
Presenter
Lauriane Cabon
Principal Scientist;
Lung Lab Head;
Investigative Safety;
Pharmaceutical Sciences, Roche Pharma Research and Early Development
View Biography
Presenter
Kyoji Tsuchikama
Associate Professor
The University of Texas Health Science Center at Houston
View Biography
Presenter
Moderator: Jerry Madukwe
Editor-in-Chief
Trends in Pharmacological Sciences